XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 2 $ 191,569 $ (137,650) $ 53,921
Balance (in shares) at Dec. 31, 2023 21,080,472      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   353   353
Exercise of stock options (in shares) 96,116      
Issuance of common stock under stock incentive plans (in shares) 229,923      
Stock-based compensation expense   1,714   1,714
Net loss     (202) (202)
Balance at Mar. 31, 2024 $ 2 193,636 (137,852) 55,786
Balance (in shares) at Mar. 31, 2024 21,406,511      
Balance at Dec. 31, 2023 $ 2 191,569 (137,650) 53,921
Balance (in shares) at Dec. 31, 2023 21,080,472      
Increase (Decrease) in Stockholders' Equity        
Net loss       (2,704)
Balance at Jun. 30, 2024 $ 2 195,774 (140,354) 55,422
Balance (in shares) at Jun. 30, 2024 21,656,683      
Balance at Mar. 31, 2024 $ 2 193,636 (137,852) 55,786
Balance (in shares) at Mar. 31, 2024 21,406,511      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   35   35
Exercise of stock options (in shares) 9,549      
Issuance of common stock under stock incentive plans   241   241
Issuance of common stock under stock incentive plans (in shares) 240,623      
Stock-based compensation expense   1,862   1,862
Net loss     (2,502) (2,502)
Balance at Jun. 30, 2024 $ 2 195,774 (140,354) 55,422
Balance (in shares) at Jun. 30, 2024 21,656,683      
Balance at Dec. 31, 2024 $ 2 199,460 (136,869) 62,593
Balance (in shares) at Dec. 31, 2024 22,059,697      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   29   29
Exercise of stock options (in shares) 10,620      
Issuance of common stock under stock incentive plans (in shares) 281,828      
Stock-based compensation expense   1,577   1,577
Net loss     (1,166) (1,166)
Balance at Mar. 31, 2025 $ 2 201,066 (138,035) 63,033
Balance (in shares) at Mar. 31, 2025 22,352,145      
Balance at Dec. 31, 2024 $ 2 199,460 (136,869) $ 62,593
Balance (in shares) at Dec. 31, 2024 22,059,697      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)       23,353
Net loss       $ (1,836)
Balance at Jun. 30, 2025 $ 2 202,778 (138,705) 64,075
Balance (in shares) at Jun. 30, 2025 22,570,591      
Balance at Mar. 31, 2025 $ 2 201,066 (138,035) 63,033
Balance (in shares) at Mar. 31, 2025 22,352,145      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   39   39
Exercise of stock options (in shares) 12,733      
Issuance of common stock under stock incentive plans   254   254
Issuance of common stock under stock incentive plans (in shares) 205,713      
Stock-based compensation expense   1,419   1,419
Net loss     (670) (670)
Balance at Jun. 30, 2025 $ 2 $ 202,778 $ (138,705) $ 64,075
Balance (in shares) at Jun. 30, 2025 22,570,591